Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow gross margin
Gross margin is gross profit as a percentage of revenue.
Harrow's gross margin for the twelve months ending Sep 30, 2026 was 73.5%. For fiscal 2025 it was 75.1%, against 75.3% the year before. The highest annual figure on record is 100.0% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75.1% | −0.3 |
| FY2024 | Dec 31, 2024 | 75.3% | +5.8 |
| FY2023 | Dec 31, 2023 | 69.6% | −1.8 |
| FY2022 | Dec 31, 2022 | 71.3% | −3.5 |
| FY2021 | Dec 31, 2021 | 74.9% | +4.5 |
| FY2020 | Dec 31, 2020 | 70.4% | +3.1 |
| FY2019 | Dec 31, 2019 | 67.3% | +7.2 |
| FY2018 | Dec 31, 2018 | 60.1% | +10.5 |
| FY2017 | Dec 31, 2017 | 49.6% | −1.1 |
| FY2016 | Dec 31, 2016 | 50.7% | +4.3 |
| FY2015 | Dec 31, 2015 | 46.4% | +12.3 |
| FY2014 | Dec 31, 2014 | 34.2% | −65.8 |
| FY2013 | Dec 31, 2013 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 75.4% | +0.2 |
| Q2 FY2026 | Jun 30, 2026 | 71.3% | −3.3 |
| Q1 FY2026 | Mar 31, 2026 | 61.2% | −6.4 |
| Q4 FY2025 | Dec 31, 2025 | 79.3% | +0.4 |
| Q3 FY2025 | Sep 30, 2025 | 75.3% | −0.3 |
| Q2 FY2025 | Jun 30, 2025 | 74.5% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | 67.5% | −1.9 |
| Q4 FY2024 | Dec 31, 2024 | 78.8% | +9.9 |
| Q3 FY2024 | Sep 30, 2024 | 75.6% | +5.0 |
| Q2 FY2024 | Jun 30, 2024 | 74.4% | +4.3 |
| Q1 FY2024 | Mar 31, 2024 | 69.5% | +1.2 |
| Q4 FY2023 | Dec 31, 2023 | 68.9% | −0.8 |
| Q3 FY2023 | Sep 30, 2023 | 70.6% | +0.1 |
| Q2 FY2023 | Jun 30, 2023 | 70.1% | −1.9 |
| Q1 FY2023 | Mar 31, 2023 | 68.3% | −4.7 |
| Q4 FY2022 | Dec 31, 2022 | 69.7% | −5.2 |
| Q3 FY2022 | Sep 30, 2022 | 70.6% | −3.0 |
| Q2 FY2022 | Jun 30, 2022 | 72.0% | −3.7 |
| Q1 FY2022 | Mar 31, 2022 | 73.0% | −2.5 |
| Q4 FY2021 | Dec 31, 2021 | 74.8% | +1.8 |
| Q3 FY2021 | Sep 30, 2021 | 73.6% | −0.8 |
| Q2 FY2021 | Jun 30, 2021 | 75.6% | +15.4 |
| Q1 FY2021 | Mar 31, 2021 | 75.6% | +6.3 |
| Q4 FY2020 | Dec 31, 2020 | 73.0% | +1.3 |
| Q3 FY2020 | Sep 30, 2020 | 74.3% | +6.2 |
| Q2 FY2020 | Jun 30, 2020 | 60.2% | −1.1 |
| Q1 FY2020 | Mar 31, 2020 | 69.3% | +1.0 |
| Q4 FY2019 | Dec 31, 2019 | 71.7% | +7.7 |
| Q3 FY2019 | Sep 30, 2019 | 68.2% | +7.2 |
| Q2 FY2019 | Jun 30, 2019 | 61.3% | +1.4 |
| Q1 FY2019 | Mar 31, 2019 | 68.3% | +14.2 |
| Q4 FY2018 | Dec 31, 2018 | 64.0% | +11.1 |
| Q3 FY2018 | Sep 30, 2018 | 61.0% | +13.5 |
| Q2 FY2018 | Jun 30, 2018 | 60.0% | +7.9 |
| Q1 FY2018 | Mar 31, 2018 | 54.1% | +9.1 |
| Q4 FY2017 | Dec 31, 2017 | 52.9% | +5.9 |
| Q3 FY2017 | Sep 30, 2017 | 47.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 52.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 44.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 47.0% | – |
See a number that looks wrong?